We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Details ‘Delaying, Denying, Limiting or Refusing’ Drug or Device Inspections
FDA Details ‘Delaying, Denying, Limiting or Refusing’ Drug or Device Inspections
To clear up any confusion about what the FDA considers delaying, denying, limiting, or refusing a drug or device inspection, the agency released a draft guidance on Thursday.